Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartwatch study aims to crack the code on Long-Term exercise for chronic illness

NCT ID NCT07495891

Knowledge-focused Sponsor: Hopital La Musse Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how different exercise programs affect fitness and motivation in people with chronic diseases. 280 participants will either exercise twice a week for 3 months or once a week for 6 months, and some will use a smartwatch to track activity. Researchers will follow them for 18 months to see which approach leads to lasting improvements.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
adapted physical activity program and smartwatch
What this could lead to
If successful, this could show the best way to design exercise programs for people with chronic diseases, potentially improving long-term fitness and motivation.
What could go wrong
This is an observational-style trial with no new drug or treatment. It may not find clear differences between groups, and results may not apply to all chronic conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 280 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients over the age of 18 * French-speaking patients * Patients with a chronic condition diagnosed by a doctor * Patients with a doctor's prescription for APA * Patients capable of understanding instructions * Patients enrolled in the Social Security system * Patients referred to Maison Sport Santé La Musse by a doctor for the first time Non inclusion Criteria : * Medical contraindications to physical exertion * Pregnant women * Individuals under legal guardianship, conservatorship, or judicial protection. * Severe cognitive or motor impairment * Lack of proficiency in French * Patients in the acute phase requiring specialized care * Patients simultaneously participating in another interventional research study * Inability to attend sessions regularly or adhere to the schedule of evaluations. * Patients who have already completed a program at the Maison Sport Santé Exclusion Criteria: * Completion of fewer than 16 APA sessions (less than 70% of sessions) * Acute exacerbation of a chronic condition during follow-up * For groups without smartwatches, the use of a digital tool such as a physical activity tracker by participants would constitute an exclusion criterion * Completion of a patient therapeutic education program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adapted physical activity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adapted physical activity Chronic disease Motivation for physical activity Physical fitness Smartwatches

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.